Introduction to polymeric in situ forming hydrogels for ophthalmic drug delivery
Stimuli-Responsive Hydrogels for Ophthalmic Drug Delivery, Page: 29-56
2024
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Book Chapter Description
Ocular drug delivery is a complex and challenging field that requires innovative approaches to improve drug efficacy and patient compliance. In this introductory chapter, we provide an overview of the use of polymeric in situ forming hydrogels as a promising strategy for enhancing ophthalmic drug delivery. This chapter begins by highlighting the importance of effective drug delivery to the eye and the unique anatomical and physiological barriers that make this task particularly challenging. It underscores the critical need for controlled and sustained drug release within the ocular environment. As we conclude this introductory chapter, we also touch upon recent advancements and emerging trends in the field, such as stimuli-responsive hydrogels and nanotechnology-based approaches, which hold great promise for achieving precise control over drug release and optimizing therapeutic outcomes in ophthalmology. In summary, this chapter serves as a foundational overview, laying the groundwork for the subsequent chapters in this book dedicated to exploring the intricacies, challenges, and innovations in the realm of polymeric in situ forming hydrogels for ophthalmic drug delivery. It is intended to be a valuable resource for researchers, clinicians, and pharmaceutical scientists seeking to navigate and contribute to this evolving field.
Bibliographic Details
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know